Novartis sells Ringaskiddy facility in Cork to Sterling Pharma SolutionsBlathnaid O’Deaon March 2, 2022 at 10:03 Silicon RepublicSilicon Republic


Pharmaceutical multinational Novartis has agreed to sell its Ringaskiddy, Co Cork manufacturing facility to UK headquartered manufacturing and development company Sterling Pharma Solutions. Financial terms of the deal were undisclosed.

The transaction will be formally closed later this year. Under the agreement, Sterling will acquire and operate the pharma giant’s Ringaskiddy facility which will still remain linked with Novartis.

Sterling will continue to manufacture Novartis’ immunology and oncology medicines onsite. Novartis’ integrated services division will also remain at the Ringaskiddy site. The company’s gene therapy centre, medicines division and global services centre are all located in Dublin.

In a company statement, Novartis its move was “a continuation of the site’s transformation journey to support a more sustainable future.”

It added that the agreement with Sterling would “secure the continued manufacturing of medicines and significant expertise in Ringaskiddy.”

Novartis employs around 1,500 people in Ireland, with approximately 400 of those based at Ringaskiddy.

Maeve Byrne, managing director said of the Cork facility commented: “We are very proud of our colleagues, who have achieved an excellent reputation for high quality, reliable production over the last 27 years. We are pleased to have secured the continued manufacturing of Novartis medicines in Ringaskiddy by Sterling, as well as to support the sustainability of jobs with significant expertise.”

Audrey Derveloy, country president of Novartis in Ireland thanked colleagues at Novartis Ringaskiddy for “their ongoing commitment.” She added that she was assuring them that the company would support them “throughout the transition process.”

Novartis’ head of its global services centre in Dublin Ciara O’Connell recently told that the company’s centre was its leading digital science centre globally thanks to Ireland’s tech ecosystem and talent pool.

Don’t miss out on the knowledge you need to succeed. Sign up for the Daily Brief, Silicon Republic’s digest of need-to-know sci-tech news.

The post Novartis sells Ringaskiddy facility in Cork to Sterling Pharma Solutions appeared first on Silicon Republic.

Leave a Comment